Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02652481 · ClinicalTrials.gov registry record · NA
ENABLE MRI (Magnetic Resonance Imaging)
A NA study, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- NA
- Development phase
- 500
- Enrollment target
NCT02652481 is a NA study that has completed, run by Boston Scientific Corporation. The registered enrollment target is 500 participants.
The verdict
NCT02652481, a NA study, has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 500 participants
- Enrollment target
Study Summary
The objective of this study is to collect data to confirm the safety and effectiveness of the Image Ready™ MR (Magnetic Resonance) Conditional Defibrillation System when used in the 1.5T (Tesla) MRI environment under the labeled Conditions of Use (Phase I). Additionally, the study will assess medically necessary MR scans according to the labeled Conditions of Use to provide real-world scanning data (Phase I and Phase II).The study also aims to demonstrate the continued ability of the ImageReady MR Conditional Defibrillation System to sense and detect ventricular fibrillation (VF) post MRI scan by collecting and analyzing data from spontaneous VF episodes, "for-cause" VF inductions, and from an optional VF induction Sub-study. .
Interventions
- DEVICE ImageReady MR Conditional Defibrillation System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2016-01 |
| Est. Completion | 2018-05-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02652481
The ClinicalTrials.gov registry entry for NCT02652481 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ImageReady MR Conditional Defibrillation System is the first listed.
NCT02652481 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02652481 about?
NCT02652481 is a clinical study titled "ENABLE MRI (Magnetic Resonance Imaging)". The objective of this study is to collect data to confirm the safety and effectiveness of the Image Ready™ MR (Magnetic Resonance) Conditional Defibrillation System when used in the 1.5T (Tesla) MRI environment under the labeled Conditions of Use (Phase I). Additionally, the study will assess medic...
What is the current status of trial NCT02652481?
This trial is currently completed. It is a NA study. The enrollment target is 500 participants. The study started on 2016-01. Estimated completion is 2018-05-04.
What interventions are being tested in trial NCT02652481?
The interventions under investigation include: ImageReady MR Conditional Defibrillation System (DEVICE).
Who is sponsoring clinical trial NCT02652481?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.